Novo Holdings A/S 13D/13G Filings for Verona Pharma plc (VRNA)

Novo Holdings A/S 13D and 13G filings for Verona Pharma plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-05
4:38 pm
Sale		 2021-02-02 13G Verona Pharma plc
VRNA		 Novo Holdings A/S 12,893,250
3.100%		 -9,746,417decrease
(-43.05%)		 Filing
2020-10-05
4:47 pm
Sale		 2020-09-30 13D Verona Pharma plc
VRNA		 Novo Holdings A/S 22,639,667
5.400%		 -408,832decrease
(-1.77%)		 Filing
2020-07-24
4:30 pm
Purchase		 2020-07-22 13D Verona Pharma plc
VRNA		 Novo Holdings A/S 23,048,499
5.500%		 8,888,888increase
(+62.78%)		 Filing